This inventor holds 1 USPTO granted patent. Top assignee: Inje University Industry-Academic Cooperation Foundation. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Whui Su Shim: Innovator in Dry Eye Syndrome Treatment
Introduction
Whui Su Shim is a notable inventor based in Icheon-si, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of dry eye syndrome. His innovative approach combines advanced materials to enhance therapeutic efficacy.
Latest Patents
Whui Su Shim holds a patent for a composition aimed at preventing or treating dry eye syndrome. This composition includes a nanocomposite of polyethylene glycol and flavonoids as active ingredients. The invention focuses on a catechin/PEG nanocomposite that increases catechin bioavailability. This formulation has been shown to enhance tear generation, stabilize corneal epithelial cells, increase conjunctival goblet cells, and provide enhanced anti-inflammatory effects in a mouse model with dry eye syndrome.
Career Highlights
Whui Su Shim is affiliated with the Inje University Industry-Academic Cooperation Foundation. His work at this institution has allowed him to bridge the gap between academic research and practical applications in the medical field. His dedication to innovation in treatment options for dry eye syndrome has positioned him as a key figure in this area of research.
Collaborations
Whui Su Shim collaborates with esteemed colleagues, including Jae Wook Yang and Hye Sook Lee. Their combined expertise contributes to the advancement of research and development in ophthalmic treatments.
Conclusion
Whui Su Shim's innovative work in developing a composition for treating dry eye syndrome showcases his commitment to improving patient care through scientific research. His contributions are paving the way for more effective treatments in the field of ophthalmology.